中国肝移植的发展与创新

沈中阳

doi:10.3969/j.issn.1001-5256.2019.11.001

中国肝移植的发展与创新

DOI: 10.3969/j.issn.1001-5256.2019.11.001

沈中阳

天津市第一中心医院器官移植中心

详细信息

中图分类号: R657.3
计量
- 文章访问数: 1304
- HTML全文浏览量: 22
- PDF下载量: 479
- 被引次数: 0
出版历程
- 收稿日期: 2019-10-08
- 出版日期: 2019-11-20

Development and innovation of liver transplantation in China

Shen ZhongYang

Center of Organ Transplantation,Tianjin First Central Hospital

摘要

摘要: 中国肝移植事业经过20年的快速发展,已成为国际肝移植舞台中的重要一员。针对乙型肝炎相关性肝病和肝癌,我国推出了符合自身国情的肝移植相关指南和标准,进一步扩大了肝移植受助人群。同时,科技水平的进步有力促进了我国肝移植外科技术的不断创新,在腔镜供体手术、异种肝移植、无缺血肝移植、活体肝移植等方面我国已然走在了世界前列。目前,供体短缺仍然是限制我国肝移植事业发展的重要因素之一,我国器官捐献工作任重而道远。
- 肝移植 /
- 适应证 /
- 组织供者
Abstract: After 20 years of rapid development,liver transplantation in China has become an important part of this field in the world. In response to hepatitis B-associated liver disease and liver cancer,China has issued the guidelines and standards for liver transplantation in line with our own national conditions and has thus further expanded the number of liver transplantation recipients. At the same time,the improvement in science and technology has effectively promoted the continuous innovation of the surgical techniques of liver transplantation in China,and China has become one of the leading countries in the fields of laparoscopic donor surgery,xenogeneic liver transplantation,non-ischemic liver transplantation,and living donor liver transplantation. At present,donor shortage remains one of the important factors that limit the development of liver transplantation in China. The organ donation work in China has a long way to go. There is still a long way to go for organ donation in China.
- liver transplantation /
- indications /
- tissue donors

HTML全文

参考文献(63)

[1] STARZL TE,MARCHIORO TL,VONKAULLA KN,et al. Homotransplantation of the liver in humans[J]. Surg Gynecol Obstet,1963,117:659-676.

[2] WU J,ZHENG SS. Liver transplantation in China:Problems and their solutions[J]. Hepatobiliary Pancreat Dis Int,2004,3(2):170-174.

[3] NG KK,LO CM. Liver transplantation in Asia:Past,present and future[J]. Ann Acad Med Singapore,2009,38(4):322-310.

[4] CHEN GH. Liver transplantation in China:Retrospect and prospect[J]. Chin Med J(Engl),2009,122(19):2229-2230.

[5] RAKELA J,FUNG JJ. Liver transplantation in China[J]. Liver Transpl,2007,13(2):182.

[6] FAN SD,WU Y. Progress of liver transplantation in Hong Kong[J]. Chin J Gen Surg,1999,14(1):5.(in Chinese)范上达，吴阳．香港肝移植的进展[J]．中华普通外科杂志，1999,14(1):5.

[7] YAN LN. Indications and operation timing of liver transplantation patients[J]. Chin J Modern Operative Surg,2001,5(1):3-4.(in Chinese)严律南．肝脏移植病人的适应证及手术时机选择[J]．中国现代手术学杂志，2001,5(1):3-4.

[8] SHEN ZY,ZHU ZJ,DENG YL,et al. Combination of lowdose HBIg and Nucleoside analogues to prevent recurrent hepatitis B virus after liver transplantation:A retrospective analysis of 1506 cases[J]. Chin J Hepatobiliary Surg,2011,17(5):364-366.(in Chinese)沈中阳，朱志军，邓永林，等．小剂量HBIg联合核苷类似物预防肝移植术后乙肝复发1506例回顾性分析[J]．中华肝胆外科杂志，2011,17(5):364-366.

[9] WANG ZF,ZHU ZJ,SHEN ZY. Advances in prophylaxis and treatment of recurrent hepatitis B after liver transplantation[J].Hepatobiliary Pancreat Dis Int,2005,4(4):509-514.

[10] YUEN MF,HOU JL,CHUTAPUTTI A,et al. Hepatocellular carcinoma in the Asia pacific region[J]. J Gastroenterol Hepatol,2009,24(3):346-353.

[11] ZHANG BH,YANG BH,TANG ZY. Randomized controlled trial of screening for hepatocellular carcinoma[J]. J Cancer Res Clin Oncol,2004,130(7):417-422.

[12] SINGAL A,VOLK ML,WALJEE A,et al. Meta-analysis:Surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis[J]. Aliment Pharmacol Ther,2009,30(1):37-47.

[13] BERHANE S,TOYODA H,TADA T,et al. Role of the GALAD and BALAD-2 serologic models in diagnosis of hepatocellular carcinoma and prediction of survival in patients[J]. Clin Gastroenterol Hepatol,2016,14(6):875-886. e6.

[14] KHALILI K,KIM TK,JANG HJ,et al. Optimization of imaging diagnosis of 1-2 cm hepatocellular carcinoma:An analysis of diagnostic performance and resource utilization[J]. J Hepatol,2011,54(4):723-728.

[15] SAPISOCHIN G,BRUIX J. Liver transplantation for hepatocellular carcinoma:Outcomes and novel surgical approaches[J]. Nat Rev Gastroenterol Hepatol,2017,14(4):203-217.

[16] YU B,DING YM,LIAO XF,et al. Prognosis of patients with single hepatocellular carcinoma meeting Milan criteria,UCSF criteria or Shanghai criteria after liver transplantation:A retrospective study based on SEER database[J]. China Cancer,2018,27(8):613-618.(in Chinese)余斌，丁佑铭，廖晓锋，等．符合米兰标准、UCSF标准和上海复旦标准的单发肝癌肝移植受者的预后比较:一项基于SEER数据库的回顾性研究[J]．中国肿瘤，2018,27(8):613-618.

[17] PAN C,GUO QJ,JIANG WT,et al. Application of modified eversion thrombectomy for portal vein thrombosis in patients undergoing liver transplantation[J]. Chin J Organ Transplant,2018,39(12):730-733.(in Chinese)潘澄，郭庆军，蒋文涛，等．改良外翻式门静脉血栓切除术在肝移植术中的应用[J]．中华器官移植杂志，2018,39(12):730-733.

[18] LI JJ,JIANG WT,TIAN DZ,et al. The effect of interventional therapy for early portal vein thrombosis after liver transplantation[J/CD]. Prac J Organ Transplant(Electronic Version),2017,5(4):271-273.(in Chinese)李俊杰，蒋文涛，田大治，等．肝移植术后早期门静脉血栓的介入治疗效果分析[J/CD]．实用器官移植电子杂志，2017,5(4):271-273.

[19] PONZIANI FR,ZOCCO MA,SENZOLO M,et al. Portal vein thrombosis and liver transplantation:Implications for waiting list period,surgical approach,early and late follow-up[J].Transplant Rev(Orlando),2014,28(2):92-101.

[20] WAN P,XU D,ZHANG J,et al. Liver transplantation for biliary atresia:A nationwide investigation from 1996 to 2013 in mainland China[J]. Pediatr Transplant,2016,20(8):1051-1059.

[21] OISHI K,ARNON R,WASSERSTEIN MP,et al. Liver transplantation for pediatric inherited metabolic disorders:Considerations for indications, complications, and perioperative management[J]. Pediatr Transplant,2016,20(6):756-769.

[22] GAO W,WANG K,MA N,et al. Living donor liver transplantations for pediatric patients withbiliary atresia in a single center:306[J]. Chin J Organ Transplant,2019,40(1):13-17.(in Chinese)高伟，王凯，马楠，等．亲属活体肝移植治疗儿童胆道闭锁306例临床分析[J]．中华器官移植杂志，2019,40(1):13-17.

[23] CHOUDHARY NS,SAIGAL S,SARAF N,et al. Outcome of living donor liver transplantation for wilson’s disease in adults:A single center experience[J]. J Clin Exp Hepatol,2018,8(2):132-135.

[24] DHAWAN A,TAYLOR RM,CHEESEMAN P,et al. Wilson’s disease in children:37-year experience and revised King’s score for liver transplantation[J]. Liver Transpl,2005,11(4):441-448.

[25] JIANG WT,PAN C,SHEN ZY,et al. Assisted laparoscopic hepatectomy on right liver living donor with middle hepatic vein:7 cases report[J]. Chin J Hepatobiliary Surg,2012,18(7):526-528.(in Chinese)蒋文涛，潘澄，沈中阳，等．腔镜辅助带肝中静脉活体右半肝供肝切取技术:附七例报道[J]．中华肝胆外科杂志，2012,18(7):526-528.

[26] MOHIUDDIN MM,SINGH AK,CORCORAN PC,et al. Chimeric 2C10R4 anti-CD40 antibody therapy is critical for longterm survival of GTKO. h CD46. h TBM pig-to-primate cardiac xenograft[J]. Nat Commun,2016,7:11138.

[27] IWASE H,LIU H,WIJKSTROM M,et al. Pig kidney graft survival in a baboon for 136 days:Longest life-supporting organ graft survival to date[J]. Xenotransplantation,2015,22(4):302-309.

[28] SHAH JA,NAVARRO-ALVAREZ N,DEFAZIO M,et al. A bridge to somewhere:25-day survival after pig-to-baboon liver xenotransplantation[J]. Ann Surg,2016,263(6):1069-1071.

[29] MOON HH,KIM TS,SONG S,et al. Early vs late liver retransplantation:Different characteristics and prognostic factors[J].Transplant Proc,2018,50(9):2668-2674.

[30] MASIORL，GRAT M,KRASNOD BSKI M,et al. Prognostic factors and outcomes of patients after liver retransplantation[J]. Transplant Proc,2016,48(5):1717-1720.

[31] KAMEI H,AL-BASHEER M,SHUM J,et al. Comparison of short-and long-term outcomes after early versus late liver retransplantation:A single-center experience[J]. J Surg Res,2013,185(2):877-882.

[32] YOO PS,UMMAN V,RODRIGUEZ-DAVALOS MI,et al. Retransplantation of the liver:Review of current literature for decision making and technical considerations[J]. Transplant Proc,2013,45(3):854-859.

[33] SHEN ZY,GU C,ZHENG H,et al. 20 years review of clinical liver transplantation[J]. Chin Critical Care Med,2019,31(3):269-280.(in Chinese)沈中阳，谷川，郑虹，等．临床肝脏移植20年回顾[J]．中华危重病急救医学，2019,31(3):269-280.

[34] HE XS,GUO ZY. Organ transplantation will usher in the era of“no ischemia”—the first successful“no ischemia”liver transplantation in the world[J]. Natl Med J China,2017,97(36):2810-2811.(in Chinese)何晓顺，郭志勇．器官移植将迎来“无缺血”时代———全球首例“无缺血”肝脏移植获得成功[J]．中华医学杂志，2017,97(36):2810-2811.

[35] RAVIKUMAR R,JASSEM W,MERGENTAL H,et al. Liver transplantation after ex vivo normothermic machine preservation:A phase 1(first-in-man)clinical trial[J]. Am J Transplant,2016,16(6):1779-1787.

[36] BHAMIDIMARRI KR,BEDUSCHI T,VIANNA R. Multivisceral transplantation:Where do we stand[J]. Clin Liver Dis,2014,18(3):661-674.

[37] BHARADWAJ S,TANDON P,GOHEL TD,et al. Current status of intestinal and multivisceral transplantation[J]. Gastroenterol Rep(Oxf),2017,5(1):20-28.

[38] COSTA G,PAREKH N,OSMAN M,et al. Composite and multivisceral transplantation:Nomenclature,surgical techniques,current practice,and long-term outcome[J]. Surg Clin North Am,2019,99(1):129-151.

[39] GARCIA MARTINEZ JJ,BENDJELID K. Artificial liver support systems:What is new over the last decade[J]. Ann Intensive Care,2018,8(1):109.

[40] BANARES R,CATALINA MV,VAQUERO J. Liver support systems:Will they ever reach prime time[J]. Curr Gastroenterol Rep,2013,15(3):312.

[41] SHEN Y,WANG Y,SHI Y,et al. Development of liposome as a novel adsorbent for artificial liver support system in liver failure[J]. J Liposome Res,2019,2:1-9.

[42] WU J,TANG Q,SHEN J,et al. Comparative proteome profile during the early period of small-for-size liver transplantation in rats revealed the protective role of Prdx5[J]. J Hepatol,2010,53(1):73-83.

[43] FANG CH,LI XF,LU ZM,et al. Application of visible simulation surgery in living donor liver transplantation[J]. J Clin Rehabil Tissue Eng Res,2008,12(39):7751-7754.(in Chinese)方驰华，李晓锋，鲁朝敏，等．可视化仿真手术在活体肝移植中的应用价值[J]．中国组织工程研究与临床康复，2008,12(39):7751-7754.

[44] ZEIN NN,HANOUNEH IA,BISHOP PD,et al. Three-dimensional print of a liver for preoperative planning in living donor liver transplantation[J]. Liver Transpl,2013,19(12):1304-1310.

[45] Chinese Society of Digital Medicine,Chinese Medical Association; Digital Surgery Committee of Chinese Research Hospital Association; Professional Committee of Medical Image and Equipment,China Graphics Society; Molecular Imaging Professional Committee of Biophysical Society of China. Expert consensus on application of computer-assisted indocyanine green molecular fluorescence imaging technology in the diagnosis and surgical navigation of liver tumor[J]. Chin J Pract Surg,2017,37(5):531-538.(in Chinese)中华医学会数字医学分会，中国研究型医院学会数字医学临床外科专业委员会，中国图学学会医学图像与设备专业委员会，中国生物物理学会分子影像学专业委员会．计算机辅助联合吲哚菁绿分子荧光影像技术在肝脏肿瘤诊断和手术导航中的应用专家共识[J]．中国实用外科杂志，2017,37(5):531-538.

[46] CHEN ZH. Organ transplantation 2019:Opportunities and challenges[J]. Chin J Organ Transplant,2019,40(1):1-2.(in Chinese)陈忠华．器官移植2019———机遇与挑战[J]．中华器官移植杂志，2019,40(1):1-2.

[47] DUTKOWSKI P,POLAK WG,MUIESAN P,et al. First comparison of hypothermic oxygenated perfusion versus static cold storage of human donation after cardiac death liver transplants:An international-matched case analysis[J]. Ann Surg,2015,262(5):764-771.

[48] GUARRERA JV,HENRY SD,SAMSTEIN B,et al. Hypothermic machine preservation facilitates successful transplantation of“orphan”extended criteria donor livers[J]. Am J Transplant,2015,15(1):161-169.

[49] JOCHMANS I,AKHTAR MZ,NASRALLA D,et al. Past,present,and future of dynamic kidney and liver preservation and resuscitation[J]. Am J Transplant,2016,16(9):2545-2555.

[50] RAVIKUMAR R,LEUVENINK H,FRIEND PJ. Normothermic liver preservation:A new paradigm[J]. Transpl Int,2015,28(6):690-699.

[51] YU Y,CHENG Y,PAN Q,et al. Effect of the selective NLRP3inflammasome inhibitor mcc950 on transplantation outcome in a pig liver transplantation model with organs from donors after circulatory death preserved by hypothermic machine perfusion[J]. Transplantation,2019,103(2):353-362.

[52] XUE S,HE W,ZENG X,et al. Hypothermic machine perfusion attenuates ischemia/reperfusion injury against rat livers donated after cardiac death by activating the Keap1/Nrf2-ARE signaling pathway[J]. Mol Med Rep,2018,18(1):815-826.

[53] ZHANG ZB,GAO W,LIU L,et al. Normothermic machine perfusion protects against liver ischemia-reperfusion injury during reduced-size liver transplantation in pigs[J]. Ann Transplant,2019,24:9-17.

[54] DONG C,GAO W,MA N,et al. A clinical report of split liver transplantation in pediatric recipients[J]. Chin J Organ Transplant,2017,38(8):469-473.(in Chinese)董冲，高伟，马楠，等．儿童劈离式肝移植38例临床效果分析[J]．中华器官移植杂志，2017,38(8):469-473.

[55] TENG DH. Clinical progress of split liver transplantation[J/CD]. Prac J Organ Transplant(Electronic Version),2017,5(4):309-314.(in Chinese)滕大洪．劈离式肝移植术临床进展[J/CD]．实用器官移植电子杂志，2017,5(4):309-314.

[56] YI SH,YANG Y,YI HM,et al. Clinical application of split liver transplantation in children’s liver transplantation[J]. Chin J Organ Transplant,2019,40(1):22-25.(in Chinese)易述红，杨扬，易慧敏，等．劈离式肝移植在儿童肝移植中的临床应用[J]．中华器官移植杂志，2019,40(1):22-25.

[57] CIRIA R,DAVILA D,HEATON N. Auxiliary liver transplantation in children[J]. Curr Opin Organ Transplant,2011,16(5):489-493.

[58] KASAHARA M,TAKADA Y,EGAWA H,et al. Auxiliary partial orthotopic living donor liver transplantation:Kyoto University experience[J]. Am J Transplant,2005,5(3):558-565.

[59] ZHU ZJ,WEI L,QU W,et al. First case of cross-auxiliary double domino donor liver transplantation[J]. World J Gastroenterol,2017,23(44):7939-7944.

[60] CAO SQ,ZHENG H. Clinical research progress of domino liver transplantation[J/CD]. Prac J Organ Transplant(Electronic Version),2017,5(4):298-303.(in Chinese)曹顺琪，郑虹．多米诺肝移植的临床研究进展[J/CD]．实用器官移植电子杂志，2017,5(4):298-303.

[61] QU W,WEI L,ZHU ZJ,et al. Considerations for use of domino cross-auxiliary liver transplantation in metabolic liver diseases:A review of case studies[J]. Transplantation,2019,103(9):1916-1920.

[62] QU W,ZHU ZJ,WEI L,et al. Feasibility of domino liver transplantation from hyperhomocsyteinemia[J]. Clin Res Hepatol Gastroenterol,2019.[Epub ahead of print]

[63] DONG C,GAO W,MA N,et al. Therapeutic effect of parental liver transplantation and domino-assisted liver transplantation on children with metabolic liver disease[J/CD]. Prac J Organ Transplant(Electronic Version),2018,6(6):464-466.(in Chinese)董冲，高伟，马楠，等．亲体肝移植联合多米诺辅助肝移植治疗儿童代谢性肝脏疾病疗效分析[J/CD]．实用器官移植电子杂志，2018,6(6):464-466.

施引文献

资源附件(0)

访问统计